NFKB1 and bone cancer: Moreover, the present study demonstrated that inhibition the activity of either PAR2 or NF-κB largely attenuated the upregulation of BDNF in the dorsal horn, indicating that the PAR2 - NF-κB signaling critically participate in the spinal BDNF upregulation in the bone cancer pain.